Hemophagocytic syndrome secondary to adult-onset still's disease but very similar to lymphoma

International Journal of Clinical and Experimental Pathology

Volumn 5, Issue 4, 2012, Pages 377-381

  Zhang, Xin Hua ^a   Han, Yong Mei ^a   Wang, Wen Wen ^a   Cheng, Hao ^a   Zhu, Ke Jian ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Adult onset Still's disease; Giant gastric ulcer; Hemophagocytic syndrome

Indexed keywords

CORTICOSTEROID; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ADULT; ADULT ONSET STILL DISEASE; ARTICLE; BIOPSY; CASE REPORT; CHEMICALLY INDUCED DISORDER; FEMALE; GASTROSCOPY; HEMOPHAGOCYTIC SYNDROME; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHOMA; PREDICTIVE VALUE; STOMACH ULCER; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOPSY; FEMALE; GASTROSCOPY; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; LYMPHOMA; PREDICTIVE VALUE OF TESTS; PROTON PUMP INHIBITORS; STILL'S DISEASE, ADULT-ONSET; STOMACH ULCER; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84864317487     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Larroche C, Mouthon L. Pathogenesis of hemophagocytic syndrome (HPS). Autoimmun Rev 2004; 3: 69-75.
2. Sánchez Loria DM, Moreno Alvarez MJ, Maldonado Cocco JA, Scheines EJ, Messina OD. Adult onset Still's disease: clinical features and course. Clin Rheumatol 1992; 11; 516-520.
3. Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, Kashiwazaki S, Tanimoto K, Matsumoto Y, Ota T. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992; 19: 424-430.
4. Fautrel B. Ferritin levels in adult Still's disease: any sugar? Joint Bone Spine 2002; 69: 355-357.
5. Akritidis N, Giannakakis I, Giouglis T. Ferritin levels and response to treatment in patients with Adult Still's disease. J Rheumatol 1996; 23: 201-202.
6. Lambotte O, Cacoub P, Costedoat N, Le Moel G, Amoura Z, Piette JC. High ferritin and low glycosylated ferritin may also be a marker of excessive macrophage activation. J Rheumatol 2003; 30: 1027-1028.
7. Imashuku S. Differentialdiagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment. Int J Hematol 1997; 66: 135-151.
8. Dhote R, Simon J, Papo T, Detournay B, Sailler L, Andre MH, Dupond JL, Larroche C, Piette AM, Mechenstock D, Ziza JM, Arlaud J, Labussiere AS, Desvaux A, Baty V, Blanche P, Schaeffer A, Piette JC, Guillevin L, Boissonnas A, Christoforov B. Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review. Arthritis Rheum 2003; 49: 633-639.
9. Sean Deane, Carlo Selmi, Suzanne S. Teuber, M. Eric Gershwin. Macrophage Activation Syndrome in Autoimmune Disease. Int Arch Allergy Immunol 2010; 153: 109-120.
10. Kawashima M, Yamamura M, Taniai M, Yamauchi H, Tanimoto T, Kurimoto M, Miyawaki S, Amano T, Takeuchi T, Makino H. Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease. Arthritis Rheum 2001; 44: 550-560.
11. Grom AA. Natural killer cell dysfunction: a common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis? Arthritis Rheum 2004; 50: 689-698.
12. Kelly A, Ramanan AV. Recognition and management of macrophage activation syndrome in juvenile arthritis. Curr Opin Rheumatol 2007; 19: 477-481.
13. Stephan JL, Kone-Paut I, Galambrun C, Mouy R, Bader-Meunier B, Prieur AM. Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology (Oxford) 2001; 40: 1285-1292.
14. Kumar MK, Suresh MK, Dalus D. Macrophage activation syndrome. J Assoc Physicians India 2006; 54: 238-240.
15. Lurati A, Terruzi B, Salmaso A, Demarco G, Pontikaki I, Gattinara M, Gerloni V, Fantini F. Macrophage activation syndrome (MAS) during anti-IL1 receptor therapy (anakinra) in a patient affected by systemic onset idiopathic juvenile arthritis (SOJIA): a report and review of the literature. Pediatr Rheumatol Online J 2005; 3: 79-85.
16. Barragry TP, Blatchford JW 3rd, Allen MO. Giant gastric ulcers. A review of 49 cases. Ann Surg 1986; 203: 255-259.
17. Luo JC, Chang FY, Lin HY, Lu RH, Lu CL, Chen CY, Lu RH, Lee SD. The potential risk factors leading to peptic ulcer formation in autoimmune disease patients receiving corticosteroid treatment. Aliment Pharmacol Ther 2002; 16: 1241-1248.
18. Piper JM, Ray WA, Daugherty JR, Griffin MR. Corticoid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. Ann Intern Med 1991; 114: 735-740.
19. Ravelli A. Macrophage activation syndrome. Curr Opin Rheumatol 2002; 14: 548-552.
20. Amenomori M, Migita K, Miyashita T, Yoshida S, Ito M, Eguchi K, Ezaki H. Cytomegalovirusassociated hemophagocytic syndrome in a patient with adult onset Still's disease. Clin Exp Rheumatol 2005; 23: 100-102.